RS virus

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RS virus.php on line 2
RS virus

LE WE PMID CA

RS virus

2448

RS Virus

Adenovirus

CMV

Filovirus

Hanta virus

Hendra virus

Influenza

Measles

Metapneumovirus

Nipah virus

Palivizumab ttRSVirusFprotein

Paramyxovirus

RS virus

SARS

Vaccine regulation

Varicella zoster virus

Virus (Endocytosis)

2007 1	Respiratory syncytial virus: seasonal data for regions of Florida and implications for palivizumab. [17639745] South Med J 100(7): 669-76 (2007)
2002 2	Respiratory syncytial virus infection and the primary care physician. [11902705] South Med J 95(3): 353-7 (2002)
2006 3	Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection. [16934132] Crit Care 10(4): 159 (2006)
2006 4	Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. [16859512] Crit Care 10(4): R107 (2006)
2008 5	Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants. [19707374] Biologics 2(3): 433-9 (2008)
2007 6	Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). [19707346] Biologics 1(1): 33-43 (2007)
2002 7	The quest for an efficacious antiviral for respiratory syncytial virus. [12718405] Antivir Chem Chemother 13(6): 325-44 (2002)
2007 8	VII International Symposium on Respiratory Viral Infections. [17944274] Antivir Ther 12(4 Pt B): 671-93 (2007)
2007 9	Respiratory syncytial virus infection in adults. [17944273] Antivir Ther 12(4 Pt B): 659-70 (2007)
2008 10	Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. [19049692] Health Technol Assess 12(36): iii, ix-x, 1-86 (2008)
2008 11	Human genetic factors and respiratory syncytial virus disease severity. [18854487] Clin Microbiol Rev 21(4): 686-703 (2008)
2008 12	Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. [18625684] Clin Microbiol Rev 21(3): 495-504 (2008)
2005 13	Immune responses and disease enhancement during respiratory syncytial virus infection. [16020689] Clin Microbiol Rev 18(3): 541-55 (2005)
2000 14	Respiratory syncytial virus infection in adults. [10885982] Clin Microbiol Rev 13(3): 371-84 (2000)
2000 15	Respiratory syncytial virus genetic and antigenic diversity. [10627488] Clin Microbiol Rev 13(1): 1-15, table of contents (2000)
1999 16	Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. [10194461] Clin Microbiol Rev 12(2): 298-309 (1999)
1995 17	Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. [7704893] Clin Microbiol Rev 8(1): 22-33 (1995)
1988 18	Detection, pathogenesis, and therapy of respiratory syncytial virus infections. [3060243] Clin Microbiol Rev 1(1): 27-39 (1988)
2003 19	Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response. [12969373] Cell Microbiol 5(10): 671-80 (2003)
2007 20	A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity. [17545486] Am J Physiol Lung Cell Mol Physiol 293(2): L279-80 (2007)
2007 21	A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. [17872592] Am J Respir Cell Mol Biol 37(4): 375-7 (2007)
2001 22	Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. [11254547] Am J Respir Crit Care Med 163(3 Pt 2): S18-21 (2001)
2001 23	Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. [11254546] Am J Respir Crit Care Med 163(3 Pt 2): S14-7 (2001)
2001 24	Potential mechanisms causing delayed effects of respiratory syncytial virus infection. [11254545] Am J Respir Crit Care Med 163(3 Pt 2): S10-3 (2001)
2007 25	Respiratory syncytial virus: a sleeping giant? [18055698] Eur Respir J 30(6): 1029-31 (2007)
2001 26	Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. [11829086] Eur Respir J 18(6): 1044-58 (2001)
2003 27	Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. [14654627] Pediatrics 112(6 Pt 1): 1442-6 (2003)
2003 28	Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. [12949282] Pediatrics 112(3 Pt 1): 548-52 (2003)
1979 29	The pathogenesis of respiratory viral infection. [223138] Postgrad Med J 55(640): 122-7 (1979)
2005 30	Pathogenesis of respiratory syncytial virus infection in the murine model. [16113477] Proc Am Thorac Soc 2(2): 110-5 (2005)
2002 31	Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. [12119057] Respir Res 3 Suppl 1(-): S40-5 (2002)
2002 32	Immunoprophylaxis of respiratory syncytial virus: global experience. [12119055] Respir Res 3 Suppl 1(-): S26-33 (2002)
2002 33	Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. [12119054] Respir Res 3 Suppl 1(-): S21-5 (2002)
2002 34	Potential therapeutic implications of new insights into respiratory syncytial virus disease. [12119053] Respir Res 3 Suppl 1(-): S15-20 (2002)
2002 35	Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. [12119052] Respir Res 3 Suppl 1(-): S8-14 (2002)
2006 36	Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. [17018467] Arch Pediatr Adolesc Med 160(10): 1070-6 (2006)
2003 37	Systematic review of the biology and medical management of respiratory syncytial virus infection. [12667273] Respir Care 48(3): 209-31; discussion 231-3 (2003)
2010 38	Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. [20235830] Clin Infect Dis 50(9): 1258-67 (2010)
2008 39	Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. [18181739] Clin Infect Dis 46(3): 402-12 (2008)
2007 40	A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: how real infants suffer. [17357042] J Infect Dis 195(8): 1084-6 (2007)
2010 41	Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. [20065326] Clin Microbiol Rev 23(1): 74-98 (2010)
2010 42	Evaluation of therapeutics for RSV: an important step forward. [21079265] Am J Respir Crit Care Med 182(10): 1217-9 (2010)
2008 43	Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. [18671826] Crit Care 12(4): 219 (2008)
2011 44	Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses. [21281564] Health Technol Assess 15(5): iii-iv, 1-124 (2011)
2007 45	Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program. [17487291] Can J Cardiol 23(6): 463-6 (2007)
2007 46	Respiratory syncytial virus: the possible trigger of airway remodeling through matrix metalloproteinase activation? [17254479] Chin Med J (Engl) 120(1): 3-4 (2007)
2009 47	The host response and molecular pathogenesis associated with respiratory syncytial virus infection. [19327115] Future Microbiol 4(3): 279-97 (2009)
2009 48	Viral entry mechanisms: the increasing diversity of paramyxovirus entry. [19878307] FEBS J 276(24): 7217-27 (2009)
2005 49	Respiratory syncytial virus bronchiolitis. [16396064] J Natl Med Assoc 97(12): 1708-13 (2005)
2005 50	Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. [15942295] Respiration 72(3): 263-9 (2005)
2010 51	Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. [20399493] Lancet 375(9725): 1545-55 (2010)
2010 52	Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infants. [20044846] J Manag Care Pharm 16(1): 59-66 (2010)
2009 53	Emerging drugs for respiratory syncytial virus infection. [19453286] Expert Opin Emerg Drugs 14(2): 207-17 (2009)
2008 54	Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. [18844597] Expert Rev Vaccines 7(8): 1239-55 (2008)
2011 55	Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. [21139081] Blood 117(10): 2755-63 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RS virus.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\RS virus.php on line 92